American Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.6M Sell
653,072
-9,977
-2% -$848K 2.31% 16
2026
Q1
$57.1M Buy
663,049
+176,837
+36% +$15.9M 3.07% 10
2025
Q4
$42.5M Sell
486,212
-12,847
-3% -$975K 1.87% 24
2025
Q3
$28.6M Buy
499,059
+15,537
+3% +$895K 1.14% 28
2025
Q2
$28.5M Buy
483,522
+188,681
+64% +$12.2M 1.18% 31
2025
Q1
$21.6M Buy
294,841
+261,731
+790% +$21.6M 0.88% 37
2024
Q4
$2.74M Buy
+33,110
New +$2.61M 0.1% 49

Other funds holding GMED

American Capital Management's GMED Position: Q2 2026 in Review

American Capital Management reduced its Globus Medical (GMED) stake by 1.5% in Q2 2026, selling an estimated $848K and leaving 653,072 shares worth $51.6M. The position accounts for 2.31% of the portfolio, ranked #16.

American Capital Management first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $57.1M in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • American Capital Management held 653,072 shares of Globus Medical worth $51.6M as of Q2 2026.
  • American Capital Management sold 9,977 Globus Medical shares in Q2 2026, an estimated $848K.
  • Globus Medical made up 2.31% of American Capital Management's portfolio in Q2 2026, its #16 holding.
  • American Capital Management first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • American Capital Management's Globus Medical position peaked at $57.1M in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on American Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.